Frost & Sullivan recognize GE Healthcare's continuing dominance of the North American CT markets
| Company News - GE Healthcare |
Frost & Sullivan has presented GE Healthcare with the 2006 North American CT Market Leadership Award. Each year the award goes to a company that has demonstrated leadership through the implementation of market strategy.
Frost & Sullivan has presented GE Healthcare with the 2006 North American CT Market Leadership Award. Each year Frost & Sullivan presents this Award to a company that has demonstrated market share leadership through the implementation of market strategy.
"GE Healthcare has set the pace in CT technology with a performance unmatched by its competitors," said Frost & Sullivan research analyst Nadim Daher. "Launched in 2004, GE's LightSpeed VCT helped inaugurate a new generation of CT capabilities such as scanning the heart in as little as 5 seconds, rather than just focusing on the number of slices."
The LightSpeed VCT has the highest market adoption rate in the industry, with a global installed base of over 1,500 systems.
"GE has also proven to be highly attentive to the rise of dose- consciousness among U.S. radiologists," noted Daher. "Understanding that coronary CTA, an extremely important new CT application, also happened to be one of the CT examinations with the highest-relative dose, GE released the new LightSpeed VCT XT version that offers as much as a seventy percent dose reduction with uncompromised image quality.
"GE Healthcare has set the pace in CT technology with a performance unmatched by its competitors," said Frost & Sullivan research analyst Nadim Daher. "Launched in 2004, GE's LightSpeed VCT helped inaugurate a new generation of CT capabilities such as scanning the heart in as little as 5 seconds, rather than just focusing on the number of slices."
The LightSpeed VCT has the highest market adoption rate in the industry, with a global installed base of over 1,500 systems.
"GE has also proven to be highly attentive to the rise of dose- consciousness among U.S. radiologists," noted Daher. "Understanding that coronary CTA, an extremely important new CT application, also happened to be one of the CT examinations with the highest-relative dose, GE released the new LightSpeed VCT XT version that offers as much as a seventy percent dose reduction with uncompromised image quality.
Related Articles/Posts
Tags: Frost - & - Sullivan - recognize - GE - Healthcare's - continuing - dominance - of - the - North - American - CT - markets - VCT XT - CTA
Set as favorite
Bookmark
Email this
Hits: 575
Trackback(0)
Comments (0)

Write comment





